IV 
110TH CONGRESS 
1ST SESSION 
H. RES. 335 
Expressing the sense of the House of Representatives that the President 
should declare lung cancer a public health priority and should implement 
a comprehensive interagency program to reduce the lung cancer mortality 
rate by at least 50 percent by 2015. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 24, 2007 
Mrs. CAPPS (for herself, Mr. WHITFIELD, and Mrs. CHRISTENSEN) submitted 
the following resolution; which was referred to the Committee on Energy 
and Commerce 
RESOLUTION 
Expressing the sense of the House of Representatives that 
the President should declare lung cancer a public health 
priority and should implement a comprehensive inter-
agency program to reduce the lung cancer mortality rate 
by at least 50 percent by 2015. 
Whereas lung cancer is the leading cause of cancer death for 
both men and women, accounting for 28 percent of all 
cancer deaths; 
Whereas lung cancer kills more people annually than breast 
cancer, prostate cancer, colon cancer, liver cancer, mela-
noma, and kidney cancer combined; 
Whereas, since the National Cancer Act of 1971 (Public Law 
92–218; 85 Stat. 778), coordinated and comprehensive 
VerDate Aug 31 2005 
04:11 Apr 25, 2007
Jkt 059200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HR335.IH
HR335
hmoore on PRODPC68 with HMBILLS
•HRES 335 IH 
research has raised the 5-year survival rates for breast 
cancer to 88 percent, for prostate cancer to 99 percent, 
and for colon cancer to 64 percent; 
Whereas the 5-year survival rate for lung cancer is still only 
15 percent and a similar coordinated and comprehensive 
research effort is required to achieve increases in lung 
cancer survivability rates; 
Whereas 60 percent of lung cancer cases are now diagnosed 
in nonsmokers or former smokers; 
Whereas 2⁄3 of nonsmokers diagnosed with lung cancer are 
women; 
Whereas certain minority populations, such as Black males, 
have disproportionately high rates of lung cancer inci-
dence and mortality, notwithstanding their lower smoking 
rate; 
Whereas members of the baby boomer generation are enter-
ing their sixties, the most common age at which people 
develop cancer; 
Whereas tobacco addiction and exposure to other lung cancer 
carcinogens such as Agent Orange and other herbicides 
and battlefield emissions are serious problems among 
military personnel and war veterans; 
Whereas the August 2001 Report of the Lung Cancer 
Progress Review Group of the National Cancer Institute 
stated that funding for lung cancer research was ‘‘far 
below the levels characterized for other common malig-
nancies and far out of proportion to its massive health 
impact’’; 
Whereas the Report of the Lung Cancer Progress Review 
Group identified as its ‘‘highest priority’’ the creation of 
integrated, multidisciplinary, multi-institutional research 
VerDate Aug 31 2005 
04:11 Apr 25, 2007
Jkt 059200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR335.IH
HR335
hmoore on PRODPC68 with HMBILLS
•HRES 335 IH 
consortia organized around the problem of lung cancer 
rather than around specific research disciplines; and 
Whereas the United States must enhance its response to the 
issues raised in the Report of the Lung Cancer Progress 
Review Group: Now, therefore, be it 
Resolved, That it is the sense of the House of Rep-
resentatives that the President should— 
(1) declare lung cancer a public health priority 
and immediately lead a coordinated effort to reduce 
the lung cancer mortality rate by 50 percent by 
2015; 
(2) direct the Secretary of Health and Human 
Services to increase funding for lung cancer research 
and other lung cancer-related programs as part of a 
coordinated strategy with defined goals, including— 
(A) translational research and specialized 
lung cancer research centers; 
(B) expansion of existing multi-institu-
tional, population-based screening programs in-
corporating state-of-the-art image processing, 
centralized review, clinical management, and to-
bacco cessation protocols; 
(C) research on disparities in lung cancer 
incidence and mortality rates; 
(D) graduate medical education programs 
in thoracic medicine and cardiothoracic surgery; 
VerDate Aug 31 2005 
04:11 Apr 25, 2007
Jkt 059200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR335.IH
HR335
hmoore on PRODPC68 with HMBILLS
•HRES 335 IH 
(E) new programs within the Food and 
Drug Administration to expedite the develop-
ment of chemoprevention and targeted therapies 
for lung cancer; 
(F) annual reviews by the Agency for 
Healthcare Research and Quality of lung cancer 
screening and treatment protocols; 
(G) the appointment of a lung cancer di-
rector within the Centers for Disease Control 
and Prevention with authority to improve lung 
cancer surveillance and screening programs; 
and 
(H) lung cancer screening demonstration 
programs under the direction of the Centers for 
Medicare and Medicaid Services; 
(3) direct the Secretary of Defense, in conjunc-
tion with the Secretary of Veterans Affairs, to de-
velop a broad-based lung cancer screening and dis-
ease management program among members of the 
Armed Forces and veterans, and to develop techno-
logically advanced diagnostic programs for the early 
detection of lung cancer; 
(4) appoint a Lung Cancer Scientific and Med-
ical Advisory Committee, comprised of medical, sci-
VerDate Aug 31 2005 
04:11 Apr 25, 2007
Jkt 059200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\HR335.IH
HR335
hmoore on PRODPC68 with HMBILLS
•HRES 335 IH 
entific, pharmaceutical, and patient advocacy rep-
resentatives, to— 
(A) work with the National Lung Cancer 
Public Health Policy Board described in para-
graph (5); and 
(B) report to the President and Congress 
on the progress toward and the obstacles to 
achieving the goal described in paragraph (1) of 
reducing the lung cancer mortality rate by 50 
percent by 2015; and 
(5) convene a National Lung Cancer Public 
Health Policy Board, comprised of multiagency and 
multidepartment representatives and at least 3 
members of the Lung Cancer Scientific and Medical 
Advisory Committee, to oversee and coordinate all 
efforts to accomplish the goal described in para-
graph (1) of reducing the lung cancer mortality rate 
by 50 percent by 2015. 
Æ 
VerDate Aug 31 2005 
04:11 Apr 25, 2007
Jkt 059200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\HR335.IH
HR335
hmoore on PRODPC68 with HMBILLS